GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Noul Co Ltd (XKRX:376930) » Definitions » EV-to-EBIT

Noul Co (XKRX:376930) EV-to-EBIT : -5.13 (As of May. 15, 2024)


View and export this data going back to 2022. Start your Free Trial

What is Noul Co EV-to-EBIT?

EV-to-EBIT is calculated as Enterprise Value divided by its EBIT. As of today, Noul Co's Enterprise Value is ₩81,664 Mil. Noul Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-15,934 Mil. Therefore, Noul Co's EV-to-EBIT for today is -5.13.

The historical rank and industry rank for Noul Co's EV-to-EBIT or its related term are showing as below:

XKRX:376930' s EV-to-EBIT Range Over the Past 10 Years
Min: -14.12   Med: -6.06   Max: -3.56
Current: -5.13

During the past 5 years, the highest EV-to-EBIT of Noul Co was -3.56. The lowest was -14.12. And the median was -6.06.

XKRX:376930's EV-to-EBIT is ranked worse than
100% of 102 companies
in the Medical Diagnostics & Research industry
Industry Median: 22.1 vs XKRX:376930: -5.13

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %. Noul Co's Enterprise Value for the quarter that ended in Dec. 2023 was ₩138,193 Mil. Noul Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 was ₩-15,934 Mil. Noul Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 was -11.53%.


Noul Co EV-to-EBIT Historical Data

The historical data trend for Noul Co's EV-to-EBIT can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Noul Co EV-to-EBIT Chart

Noul Co Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23
EV-to-EBIT
- - - -7.43 -8.72

Noul Co Quarterly Data
Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
EV-to-EBIT Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -7.43 -5.60 -5.47 -14.94 -8.72

Competitive Comparison of Noul Co's EV-to-EBIT

For the Diagnostics & Research subindustry, Noul Co's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Noul Co's EV-to-EBIT Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Noul Co's EV-to-EBIT distribution charts can be found below:

* The bar in red indicates where Noul Co's EV-to-EBIT falls into.



Noul Co EV-to-EBIT Calculation

Noul Co's EV-to-EBIT for today is calculated as:

EV-to-EBIT=Enterprise Value (Today)/EBIT (TTM)
=81664.074/-15934.14
=-5.13

Noul Co's current Enterprise Value is ₩81,664 Mil.
Noul Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-15,934 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Noul Co  (XKRX:376930) EV-to-EBIT Explanation

This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.

Joel Greenblatt calls the inversion of this ratio Earnings Yield (Joel Greenblatt) %.

Noul Co's Earnings Yield (Joel Greenblatt) % for the quarter that ended in Dec. 2023 is calculated as:

Earnings Yield (Joel Greenblatt) % (Q: Dec. 2023 ) =EBIT / Enterprise Value (Q: Dec. 2023 )
=-15934.14/138193.238
=-11.53 %

Noul Co's Enterprise Value for the quarter that ended in Dec. 2023 was ₩138,193 Mil.
Noul Co's EBIT for the trailing twelve months (TTM) ended in Dec. 2023 adds up the quarterly data reported by the company within the most recent 12 months, which was ₩-15,934 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Noul Co EV-to-EBIT Related Terms

Thank you for viewing the detailed overview of Noul Co's EV-to-EBIT provided by GuruFocus.com. Please click on the following links to see related term pages.


Noul Co (XKRX:376930) Business Description

Traded in Other Exchanges
N/A
Address
B-10F, 338, Gwanggyojungang-ro, Suji-gu, Gyeonggi-do, Yongin-si, KOR, 16942
Noul Co Ltd provides solutions for chronic and systemic problems in healthcare. The company's miLab is an all-in-one, fully-automated device which can process sample preparation and AI diagnostic in one workflow. It integrates technologies from computer vision AI, bio, hardware, and software engineering.

Noul Co (XKRX:376930) Headlines

No Headlines